Ask Warren

Hyundai Bioland

052260 · KOSDAQ · ₩052260 · 현대바이오랜드

₩4,075▼ ₩30 (0.73%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩40B₩38B₩27B₩35B₩35B₩34B₩21B₩33B
Cost of sales₩22B₩23B₩18B₩20B₩19B₩19B₩11B₩20B
Gross profit₩18B₩15B₩8.3B₩15B₩16B₩14B₩11B₩14B
Operating income₩7B₩5.2B−₩2.5B₩4.7B₩5.5B₩5B₩2.8B₩3.4B
Net income₩6B₩5.2B−₩1.8B−₩3.1B₩12B−₩7B₩2.6B−₩1.6B
Net income to shareholders₩6B₩5.2B−₩1.8B₩3.9B₩5.1B−₩7B−₩5.2B₩3.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩166B₩161B₩167B₩166B₩157B₩159B₩195B₩193B
Current assets₩93B₩87B₩92B₩91B₩82B₩83B₩107B₩90B
Cash and equivalents₩8.9B₩8.3B₩18B₩21B₩8.1B₩3.8B₩21B₩20B
Total liabilities₩21B₩22B₩31B₩28B₩22B₩30B₩57B₩48B
Current liabilities₩18B₩19B₩28B₩26B₩21B₩28B₩56B₩47B
Borrowings₩6B₩6B₩10B₩10B₩10B₩14B₩35B₩33B
Total equity₩146B₩140B₩136B₩138B₩135B₩128B₩138B₩145B
Shareholders' equity₩146B₩140B₩136B₩138B₩135B₩128B₩138B₩145B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩11B−₩1.4B₩1.9B₩14B₩3.9B−₩423M₩2.6B₩936M
Capital spending₩655M₩239M₩855M₩760M₩1.1B₩1.3B₩1.2B₩846M
Free cash flow₩10B−₩1.6B₩1.1B₩13B₩2.8B−₩1.7B₩1.3B₩90M
Dividends paid₩4.2B−₩2.1B₩0₩0₩0₩2.1B₩0₩0

Consolidated where available. Amounts in won.

Also known as: Hyundai Bioland / 현대바이오랜드 / 052260 / KRX:052260

Source: KRX statistical information